Advertisements



"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)

Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream.  In data presente.....»»

Category: topSource: businessinsiderApr 16th, 2018

20 Common Cancer Symptoms to Catch Early

Cancer patients are living longer today due to early detection and better treatment options. The number of cancer diagnoses, however, is increasing and is expected to rise to nearly 23.6 million by........»»

Category: blogSource: 247wallstMar 10th, 2020

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from........»»

Category: blogSource: 247wallstJan 21st, 2020

USF"s proposed cannabis medical program could stir up new partnerships and innovation

School officials have been interested in the program since 2014 when Gov. Rick Scott signed a bill to legalize the use of low-THC marijuana to treat epilepsy, Lou Gehrig's disease and cancer patients......»»

Category: topSource: bizjournalsAug 29th, 2019

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

A combination of Merck's Keytruda and chemotherapy cut lung cancer death rates in half. New study results released Monday continue to cemen.....»»

Category: europeSource: fortuneApr 16th, 2018

Merck"s Keytruda helps lung cancer patients live longer in trial

(Reuters) - Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in the lucrative lung cancer market......»»

Category: topSource: reutersApr 9th, 2018

Merck"s Keytruda meets main goal in pivotal lung cancer trial

(Reuters) - Merck & Co said on Monday a late-stage trial of its blockbuster cancer drug Keytruda met the main goal in helping previously untreated lung cancer patients live longer, sending its shares up 2.6 percent in premarket trade......»»

Category: topSource: reutersApr 9th, 2018

A cancer treatment that one expert called the "most exciting thing I"ve seen in my lifetime" just got approved to treat more patients (NVS, GILD)

Reuters The FDA just approved a cutting-edge .....»»

Category: topSource: businessinsiderMay 2nd, 2018

Study finds rare gain for tough-to-treat pancreatic cancer

Patients with pancreatic cancer that hadn't spread lived substantially longer on .....»»

Category: topSource: foxnewsJun 4th, 2018

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer

Cellectar Biosciences Inc. said Monday it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for a treatment for a rare kind of cancer in children cal.....»»

Category: topSource: marketwatchSep 17th, 2018

Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback

Bristol-Myers Squibb said its fourth-quarter revenue rose on sales of key drugs, but it suffered another setback entering the market to treat newly diagnosed lung-cancer patients......»»

Category: smallbizSource: wsjJan 25th, 2019

Rush partners with top-ranked MD Anderson, aiming to give patients more access to the latest cancer treatments

As part of the agreement, protocols and cancer treatment plans at Rush will mirror those available at MD Anderson. Rush University System for Health is teaming up with .....»»

Category: topSource: chicagotribuneApr 26th, 2024

Elias Animal Health seeks $10M for first-of-its-kind treatment, names new exec

Elias Animal Health is preparing to launch its first product, a potentially revolutionary bone cancer treatment for dogs......»»

Category: topSource: bizjournalsApr 10th, 2024

Skin cancer: Myths, detection, treatment and prevention

Most of us at one time or another have experienced the painful redness, peeling and even blistering resulting from a sunburn, but there are also longer-term problems such as early aging of the skin (brown spots or wrinkles) and skin cancer. Accordin.....»»

Category: topSource: bizjournalsMay 15th, 2021

Genprex in-licenses gene therapy technologies for lung cancer treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

AstraZeneca"s Tagrisso recommended in E.U. for treatment of EGFR lung cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial

"Pending regulatory approval, the recommended protocol adjustments could accelerate trial completion by more than a year," its CEO said. In this phot.....»»

Category: personnelSource: nytApr 13th, 2021

Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients

read more.....»»

Category: blogSource: benzingaApr 7th, 2021

G1 Therapeutics" Trilaciclib Wins FDA Nod For Mitigating Chemo Effects In Lung Cancer Patients

read more.....»»

Category: blogSource: benzingaFeb 16th, 2021

Heat Biologics stock more than doubles after "positive" trial data of its lung cancer treatment

Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" in.....»»

Category: topSource: marketwatchFeb 9th, 2021